SBA
TEVA icon

Seven Bridges Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Seven Bridges Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,994
Closed -$507K – 155
2016
Q4 		$507K Sell
13,994
-1,014
-7% -$40.5K 0.52% 57
2016
Q3 		$691K Sell
15,008
-7,495
-33% -$391K 0.61% 49
2016
Q2 		$1.13M Buy
22,503
+5,681
+34% +$302K 0.97% 30
2016
Q1 		$900K Buy
16,822
+12,223
+266% +$717K 0.71% 47
2015
Q4 		$302K Buy
+4,599
New +$284K 0.3% 86

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Seven Bridges Advisors's TEVA Position: Q1 2017 in Review

Seven Bridges Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 13,994 shares — an estimated $507K sold.

Seven Bridges Advisors first reported a position in TEVA in Q4 2015 and held it in 5 quarters. The position peaked at $1.13M in Q2 2016. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Seven Bridges Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Seven Bridges Advisors sold 13,994 Teva Pharmaceuticals shares in Q1 2017, an estimated $507K.
  • Seven Bridges Advisors first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 5 quarters.
  • Seven Bridges Advisors's Teva Pharmaceuticals position peaked at $1.13M in Q2 2016.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Seven Bridges Advisors's 13F filing for Q1 2017, filed 15 May 2017.